IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 244 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $19,009,336 | +42.1% | 2,974,857 | +113.0% | 0.01% | +25.0% |
| Q3 2022 | $13,377,100 | -10.5% | 1,396,357 | +3.1% | 0.00% | 0.0% |
| Q2 2022 | $14,950,754 | -33.7% | 1,354,235 | +0.0% | 0.00% | -20.0% |
| Q1 2022 | $22,539,754 | -9.3% | 1,353,739 | +4.0% | 0.01% | 0.0% |
| Q4 2021 | $24,845,000 | -18.6% | 1,301,450 | +5.1% | 0.01% | -28.6% |
| Q3 2021 | $30,534,000 | -1.0% | 1,238,198 | +4.4% | 0.01% | 0.0% |
| Q2 2021 | $30,851,000 | -20.4% | 1,185,673 | -3.2% | 0.01% | -22.2% |
| Q1 2021 | $38,765,000 | -43.3% | 1,224,416 | -16.9% | 0.01% | -43.8% |
| Q4 2020 | $68,330,000 | +35.6% | 1,472,631 | -3.8% | 0.02% | +23.1% |
| Q3 2020 | $50,373,000 | +26.6% | 1,530,154 | +5.5% | 0.01% | +18.2% |
| Q2 2020 | $39,796,000 | +1.6% | 1,449,779 | +10.8% | 0.01% | -21.4% |
| Q1 2020 | $39,184,000 | +8.1% | 1,308,979 | 0.0% | 0.01% | +40.0% |
| Q4 2019 | $36,233,000 | +227.8% | 1,308,979 | +115.5% | 0.01% | +233.3% |
| Q3 2019 | $11,055,000 | +2156.1% | 607,429 | +2937.1% | 0.00% | – |
| Q2 2019 | $490,000 | +157.9% | 20,000 | 0.0% | 0.00% | – |
| Q1 2019 | $190,000 | +7.3% | 20,000 | 0.0% | 0.00% | – |
| Q4 2018 | $177,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,876,600 | $127,618,000 | 11.48% |
| Fairmount Funds Management LLC | 596,890 | $19,650,000 | 8.32% |
| Ghost Tree Capital, LLC | 575,000 | $18,929,000 | 5.47% |
| Perceptive Advisors | 10,085,632 | $332,019,000 | 4.85% |
| Avoro Capital Advisors LLC | 9,536,039 | $313,926,000 | 4.46% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $43,224,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 315,000 | $10,370,000 | 2.82% |
| Orbimed Advisors | 6,645,100 | $218,757,000 | 2.75% |
| QVT Financial LP | 572,971 | $18,862,000 | 2.30% |
| Prosight Management, LP | 120,606 | $3,970,000 | 1.89% |